NEW YORK (GenomeWeb News) – Invitrogen said after the close of the market on Tuesday that it has received US Food and Drug Administration clearance to sell its new transplant diagnostics system.
 
The Carlsbad, Calif.-based firm received 510(k) clearance for its DynaChip Antibody Analysis System, an automated chip-based system for human leukocyte antibody detection and identification. The tests are run on protein arrays developed by the company.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.